Sign up to save your podcasts
Or
Share Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness
CME credits: 0.25
Valid until: 30-06-2022
Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-on-new-therapy-combinations-for-hfref-raising-clinician-awareness/12691/
Is it possible to reduce the nearly 60% one-month rehospitalization rates in patients with worsening heart failure? Dr. Paul Armstrong and Dr. Justin Ezekowitz discuss new therapeutic combinations including soluble guanylate cyclase (sGC) stimulators, as well as the practical applications of new evidence that was presented at the 2021 annual ACC meeting that may change how physicians approach treating their patients with worsening heart failure. Don’t miss out on new information about how sGC stimulators may benefit your patients.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 30-06-2022
Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-on-new-therapy-combinations-for-hfref-raising-clinician-awareness/12691/
Is it possible to reduce the nearly 60% one-month rehospitalization rates in patients with worsening heart failure? Dr. Paul Armstrong and Dr. Justin Ezekowitz discuss new therapeutic combinations including soluble guanylate cyclase (sGC) stimulators, as well as the practical applications of new evidence that was presented at the 2021 annual ACC meeting that may change how physicians approach treating their patients with worsening heart failure. Don’t miss out on new information about how sGC stimulators may benefit your patients.